Metraipolis › archive › dc_8f45fc6e199e

Ubrogepant Plasma and Cerebrospinal Fluid Exposures in Participants With a History of Migraine: Findings From a Phase 1b Open-Label Trial — Europe PMC PMID:42012062

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42012062
DOI
10.1111/cts.70560
License (as archived)
solo-consultazione
Archived
2026-10-09T06:36:11.982Z
SHA-256 of the archived text
77e1690ad05c19e7680b434f2b895d0a746e5d60595c21f6fd51c6e4552363ab
Stable URL of this page
https://metraipolis.com/documento/dc_8f45fc6e199e

How to cite

Ubrogepant Plasma and Cerebrospinal Fluid Exposures in Participants With a History of Migraine: Findings From a Phase 1b Open-Label Trial — Europe PMC PMID:42012062 — Europe PMC (en), https://europepmc.org/article/MED/42012062 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8f45fc6e199e (Metraipolis archive dc_8f45fc6e199e, sha256 77e1690ad05c19e7680b434f2b895d0a746e5d60595c21f6fd51c6e4552363ab)
BibTeX
@misc{dc8f45fc6e199e,
  title = {Ubrogepant Plasma and Cerebrospinal Fluid Exposures in Participants With a History of Migraine: Findings From a Phase 1b Open-Label Trial — Europe PMC PMID:42012062},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42012062},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8f45fc6e199e; sha256 77e1690ad05c19e7680b434f2b895d0a746e5d60595c21f6fd51c6e4552363ab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42012062. Agents can read the archived copy with the MCP tool read_document.